131I tositumomab -: A viewpoint by Wolfgang!Kern

被引：1

作者：

Kern, W ^{[1
]}

机构：

[1] Univ Munich, Hosp Grosshadern, Dept Internal Med 3, Munich, Germany

来源：

BIODRUGS | 2000年 / 14卷 / 03期

关键词：

D O I：

10.2165/00063030-200014030-00006

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：203 / 203

页数：1

共 50 条

[21] 131I IN THYROTOXICOSIS
STAFFURTH, JS
YOUNG, JA
BMJ-BRITISH MEDICAL JOURNAL, 1967, 1 (5540): : 629 - +
[22] DECAY OF 131I
HARGROVE, CK
CHATTERJEE, A
GEIGER, KW
NUCLEAR PHYSICS, 1963, 40 (04): : 566 - &
[23] URINARY EXCRETION OF 131I COMPOUNDS AFTER ADMINISTRATION OF 131I THYROXINE
BLOMSTEDT, B
ACTA ENDOCRINOLOGICA, 1965, 48 (03): : 481 - +
[24] Thymic uptake in 131I (131I) whole body scan.
Yeung, HW
Pandit-Taskar, N
Simon, J
Larson, SM
JOURNAL OF NUCLEAR MEDICINE, 2001, 42 (05) : 323P - 323P
[25] Efficient and Practical Radiosynthesis of Novel [131I]-Xanthine and [131I]-Hypoxanthine
Wongso, H.
Nuraeni, W.
Rosyidiah, E.
ATOM INDONESIA, 2022, 48 (03) : 185 - 191
[26] Study on removal of 131I from liquid waste in 131I production
Liu, Yishu
Han, Dongqiao
Bao, Jianying
Wang, Aimin
Cheng, Zuoyong
Chai, Dean
Hedongli Gongcheng/Nuclear Power Engineering, 1998, 19 (05): : 476 - 480
[27] A practical methodology for patient release after tositumomab and 131I-tositumomab therapy
Siegel, JA
Kroll, S
Regan, D
Kaminski, MS
Wahl, RL
JOURNAL OF NUCLEAR MEDICINE, 2002, 43 (03) : 354 - 363
[28] Iodine-131 Tositumomab131I-anti-B1 antibody, 131I-tositumomab, anti-CD20 murine monoclonal antibody-I-131, B1, Bexxar-, 131I-anti-B1 antibody, iodine-131 tositumomab, iodine-131 anti-B1 antibody, tositumomab
BioDrugs, 2003, 17 (4) : 290 - 295
[29] 131I生产废液中131I的净化方法研究
刘宜树
韩冬桥
包建英
王爱民
程作用
柴德安
核动力工程, 1998, (05) : 92 - 95
[30] Iodine-131 tositumomab -: 131I-anti-B1 antibody, 131I-tositumomab, anti-CD20 murine monoclonal antibody-I-131, B1, Bexxar™, 131I-anti-B1 antibody, iodine-131 tositumomab, iodine-131 anti-B1 antibody, tositumomab
不详
BIODRUGS, 2003, 17 (04) : 290 - 295

← 1 2 3 4 5 →